History
  • No items yet
midpage
Crozier v. Johnson & Johnson Consumer Companies, Inc.
901 F. Supp. 2d 494
D.N.J.
2012
Read the full case

Background

  • Plaintiffs allege NJCFA violations and implied warranties related to Neosporin NEO TO GO! first aid antiseptic spray sold by J&J.
  • Two nearly identical state-court complaints were removed to federal court and consolidated for pre-trial purposes under CAFA jurisdiction.
  • The spray contains benzalkonium chloride (non-antibiotic); plaintiffs contend branding mimics Neosporin products with antibiotics to mislead consumers.
  • Plaintiffs claim the price is unreasonably high relative to antiseptics due to alleged antibiotic misrepresentation; no express antibiotic claim is on the label.
  • Defendant moves to dismiss under Fed. R. Civ. P. 12(b)(6) arguing labeling preemption and failure to plead NJCFA and warranty claims with particularity.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Are labeling claims preempted by federal law? NJCFA claims target advertising/labeling; labels must reveal active ingredients; preemption arguable only if conflicting with FDA. FDCA § 379r preempts state labeling requirements for OTC drugs; labeling claims are preempted. Labeling claims preempted; marketing claims may proceed with cure; warranty claims dismissed.
Do NJCFA claims fail for lack of misrepresentation and reliance? Signature Gold Mark/trade dress misleads consumers into thinking antibiotics are present. Plaintiffs failed to plead when/where they saw ads or relied on branding; misrepresentation not pled with particularity. NJCFA claims dismissed without prejudice for lack of particularized pleadings; opportunity to amend.
Whether implied warranties claims survive given lack of defect evidence? Product lacked antibiotics and thus failed to meet merchantability/fitness for purpose. Claims improperly rest on advertising; no defect alleged affecting ordinary purpose. Breach of implied warranty claims dismissed with prejudice.

Key Cases Cited

  • Wyeth v. Levine, 555 U.S. 555 (U.S. 2009) (prescription labeling preemption does not extend to OTC drugs)
  • In re Burlington Coat Factory Sec. Litig., 114 F.3d 1410 (3d Cir. 1997) (standard for considering extrinsic materials on motion to dismiss)
  • Cipollone v. Liggett Group, Inc., 505 U.S. 504 (U.S. 1992) (Supremacy Clause and preemption framework)
  • Frederico v. Home Depot, 507 F.3d 188 (3d Cir. 2007) (NJCFA requires proof of unlawful conduct, causation, and ascertainable loss)
  • Chattin v. Cape May Greene, Inc., 243 N.J. Super. 590, 581 A.2d 91 (N.J. App. Div. 1990) (reliance requirements in NJCFA for manufacturer liability)
  • Lieberson v. Johnson & Johnson Consumer Cos., 865 F. Supp. 2d 529 (D.N.J. 2011) (puffery and pleading specificity under NJCFA; Rule 9(b) implications)
  • Smajlaj v. Campbell Soup Co., 782 F. Supp. 2d 84 (D.N.J. 2011) (NJCFA claims sound in fraud; Rule 9(b) pleading applies)
  • Frederico v. Home Depot, 507 F.3d 188 (3d Cir. 2007) (unlawful conduct categories and causation in NJCFA)
Read the full case

Case Details

Case Name: Crozier v. Johnson & Johnson Consumer Companies, Inc.
Court Name: District Court, D. New Jersey
Date Published: Sep 28, 2012
Citation: 901 F. Supp. 2d 494
Docket Number: Civil Action Nos. 12-0008 (JBS/KMW), 12-0010 (JBS/KMW)
Court Abbreviation: D.N.J.